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Abstract
The aim of this study was to clarify the factors influencing the dietary behavior of patients
with diabetic nephropathy. One hundred twenty-two patients with type 2 diabetes were recruited
from the outpatients of Okayama University Hospital in Okayama, Japan. We performed a cross-
sectional study using a questionnaire including 206 items among 18 categories as follows:background
factors, coping behavior (coping scale), degree of uncertainty in illness (uncertainty scale), and
dietary behavior. The data were analyzed by correlation analysis, t-test, one-way analysis of
variance, Pearson correlation analysis, and multiple regression analysis. We found that those
patients with microalbuminuria alone tended to recognize more mild about their kidney status
than those with macroalbuminuria and chronic renal failure. We also found that common fac-
tors influencing the dietary behavior of diabetic patients with and without nephropathy are as
follows:1. coping with the problem (beta0.342, p0.01);2. anxiety about prognosis (beta0.344,
p0.01);3. sex (beta0.234, p0.05);4. uncertainty regarding treatment (beta0.377, p0.01);5. negative
coping (beta0.354, p0.01);and 6. employment status (beta0.367, p0.01). Coping and uncertainty
in illness had a significant relation to positive support and lack of support. To maintain appropriate
dietary behavior in diabetic patients, medical staff need to determine what the social supports are
important for the patient, and also to ensure good communication among healthcare personnel as
well as positive support for patients and families.
KEYWORDS: diabetic nephropathy, dietary behavior, coping, uncertainty in illness, social sup-
port
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The aim of this study was to clarify the factors inﬂuencing the dietary behavior of patients with dia-
betic nephropathy.  One hundred twenty-two patients with type 2 diabetes were recruited from the 
outpatients of Okayama University Hospital in Okayama,  Japan.  We performed a cross-sectional 
study using a questionnaire including 206 items among 18 categories as follows: background factors,  
coping behavior (coping scale),  degree of uncertainty in illness (uncertainty scale),  and dietary behav-
ior.  The data were analyzed by correlation analysis,  t-test,  one-way analysis of variance,  Pearson 
correlation analysis,  and multiple regression analysis.  We found that those patients with microalbu-
minuria alone tended to recognize more mild about their kidney status than those with macroalbu-
minuria and chronic renal failure.  We also found that common factors inﬂuencing the dietary behav-
ior of diabetic patients with and without nephropathy are as follows: 1.  coping with the problem 
(ｹ＝0.342,  p＜0.01); 2.  anxiety about prognosis (ｹ＝－0.344,  p＜0.01); 3.  sex (ｹ＝－0.234,  p＜0.05); 4.  
uncertainty regarding  treatment (ｹ＝0.377,  p＜0.01); 5.  negative coping (ｹ＝－0.354,  p＜0.01); and 6.  
employment status (ｹ＝0.367,  p＜0.01).  Coping and uncertainty in illness had a signiﬁcant relation to 
positive support and lack of support.  To maintain appropriate dietary behavior in diabetic patients,  
medical staﬀ need to determine what the social supports are important for the patient,  and also to 
ensure good communication among healthcare personnel as well as positive support for patients and 
families.
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iabetic nephropathy is the leading cause of end-
stage renal failure in developed countries.  The 
clinical stages of diabetic nephropathy are classiﬁed as 
follows: stage 1,  normoalbuminuria (urinary albumin/
creatinine ratio (ACR)＜30mg/g creatinene); stage 2,  
microalbuminuria (30≦ACR＜300mg/g creatinine);  
stage 3,  macroalbuminuria (ACR≧300mg/g creati-
nine and/or persistent proteinuria with serum concen-
trations of creatinine＜1.2mg/dl); stage 4,  chronic 
renal failure (serum concentration of creatinine≧
1.2mg/dl with proteinuria); and stage 5,  under chronic 
dialysis therapy [1].
　 It has been considered that the progression of dis-
ease is irreversible at the stage of macroalbuminuria,  
but recent papers have suggested that remission or 
regression of diabetic nephropathy is possible at this 
D
Acta Med.  Okayama,  2010
Vol.  64,  No.  1,  pp.  39ﾝ47
CopyrightⒸ 2010 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received April 14, 2009 ; accepted September 3, 2009.
 ＊Corresponding author. Phone : ＋81ﾝ78ﾝ925ﾝ9407; Fax : ＋81ﾝ78ﾝ925ﾝ0878
E-mail : kazuko_sumiyoshi@cnas.u-hyogo.ac.jp (K. Sumiyoshi)
1
Sumiyoshi et al.: Influencing Factors for Dietary Behaviors of Patientswith Diabeti
Produced by The Berkeley Electronic Press, 2010
stage in response to appropriate treatment [2,  3].  
Although the primary treatment for diabetic neph-
ropathy varies according to the stage of the disease,  
the basic treatment involves strict control of blood 
glucose levels and blood pressure.
　 Various studies,  including a Diabetes Control and 
Complications Trial (DCCT),  have shown that glyce-
mic control is related to the development of nephropa-
thy in patients with type 1 diabetes [4].  Further-
more,  the UK Prospective Diabetes Study (UKPDS) 
[5] and Kumamoto study have shown that HbA1c 
values are related to the development of nephropathy 
in patients with type 2 diabetes.  The Kumamoto study 
suggests that no progression of nephropathy takes 
place in patients whose HbA1c is below 6.5ｵ.  Diet 
therapy and exercise are fundamental lifestyle modiﬁ-
cations that allow patients to adequately control their 
diabetes mellitus [6].
　 In order to prevent aggravation of nephropathy,  
the patients need to have a good understanding of their 
disease.  Diabetic patients in an advanced stage of 
nephropathy need strict diet therapy,  though it is well 
known that adopting an appropriate protein-restricted 
diet can be diﬃcult.  Recent studies of diabetic neph-
ropathy cover a broad range of topics,  including the 
eﬀects of a protein-restricted diet [7-9] and the 
eﬀects of drug treatment [10-21].  However,  there 
have been few studies designed to examine how 
patients understand or cope with their clinical condi-
tion [22].  In order to prevent the progression of 
nephropathy,  it is necessary to apply the appropriate 
support for cognitive features and coping behaviors of 
patients according to the stage of nephropathy.
　 The aim of this study was to clarify the factors 
related to the ability of patients to self-manage their 
disease condition.  This study also aimed to identify 
whether patients accurately perceive their own stage 
of diabetic nephropathy and to clarify the factors that 
inﬂuence the dietary behavior of patients with diabetic 
nephropathy.
Materials and Methods
　 Patients. This cross-sectional study analyzed 
the data from 122 patients with type 2 diabetes mel-
litus.  They were recruited from the diabetes outpa-
tient clinic at Okayama University Hospital from 
August 2004 to March 2005.  There were approxi-
mately 600 eligible patients that were referred by 
their physicians.  We selected 200 patients aged 18 
years or older who were capable of understanding the 
questionnaire content.  Of the 200 patients selected,  
166 agreed to participate.  After excluding the 
patients with type 1 diabetes and drug-induced diabe-
tes,  122 patients with type 2 diabetes were analyzed.
　 Methods. Patients were administered a 206-
item questionnaire during their waiting time at visits.  
The estimated administration time for the question-
naire was 40 to 60min.  When patients found the sur-
veys diﬃcult to complete on their own,  they were 
assisted by research staﬀ members.
　 This study was approved by the Ethics Committee 
of the Okayama University Hospital.  The subjects 
were informed verbally as well as in writing about the 
purpose of the study and its methods,  the voluntary 
nature of their participation in the study,  and the 
obligation of the researchers to maintain secrecy and 
not reveal any information that would identify any 
individuals.  All patients were asked to sign a consent 
form that fulﬁlled the requirements of the Ethics 
Committee.  Both the physicians and patients provided 
consent allowing us to obtain information from the 
patientsʼ clinical records to conﬁrm examination data 
and the presence of complications.
　 Clinical parameters. The following parame-
ters were examined: sex,  age,  schooling history,  
family size,  employment status,  symptoms,  duration 
of diabetes,  hemoglobinA1c (HbA1c) levels,  regimen 
of therapy,  attendance at hospital education programs,  
clinical stage of nephropathy,  awareness of microal-
buminuria or macroalbuminuria,  recognition of renal 
status,  social support,  symptom,  knowledge of neph-
ropathy,  coping behavior (coping),  degree of uncer-
tainty in illness and dietary behavior.
　 We used the Jalowiecʼs coping scale (Japanese ver-
sion) for chronic disease [23] and the MUIS-A scale 
created by Mishel [24] to measure the patientsʼ feel-
ings of uncertainty related to illness,  dietary behavior,  
the symptoms scale,  and the social support scale [25] 
(see Table 1).
　 Coping is deﬁned as constantly changing cognitive 
and behavioral eﬀorts to manage speciﬁc external 
and/or internal demands that are appraised as taxing 
or exceeding the resources of the person [26].  The 
dietary behavior scale was factor analyzed,  and 6 
items were extracted from the data.  A higher score 
40 Acta Med.  Okayama　Vol.  64,  No.  1Sumiyoshi et al.
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means that the patientʼs uncertainty is higher.  Items 
for symptoms caused by diabetes and complications 
were reviewed; 8 items dealing with symptoms were 
extracted to determine symptom progression.  A 
higher score means that the patientʼs symptoms were 
severe.  The social support scale consisted of 14 items 
and was based on Starrʼs social support questionnaire 
with the addition of 4 items dealing with medical staﬀ 
support.  A higher score reﬂects greater support.  The 
knowledge of nephropathy consisted of 10 items; a 
correct answer was counted as one point and a perfect 
score was 10 points.
　 Statistical analysis. For all scales,  an explor-
atory factor analysis was subsequently performed,  and 
the structure was checked using conﬁrmatory factor 
analysis.  Cronbachʼs alpha statistic was determined to 
assess internal consistency for all scales.  The statisti-
cal analysis used the Studentʼs t-test,  one-way analysis 
of variance,  and Pearson correlationʼ analysis of the 
background factors of the patients as well as the 
measures coping scale score,  uncertainty scale scores,  
and scores of dietary behavior.
　 Multiple regression analysis was used to identify 
which factors aﬀected the patientsʼ dietary behavior.  
The independent variables were age,  sex,  coping,  
uncertainty in illness,  social support,  whether a phy-
sician pointed out the albuminuria (proteinuria),  
knowledge of nephropathy,  family size,  and employ-
ment status; and the dependent variable was dietary 
behavior.
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Table 1　 Scales used
scales factors items Cronbachʼsalpha range mean±S.D
coping
(Jalowiecʼs coping
scale Japanese
version)
4
coping with the problem  5 0.78 0～20 11.7±4.2
expectations of treatment  3 0.51 0～12 5.3±2.7
negative coping  3 0.59 0～12 2.6±2.7
positive attitude  2 0.74 0～10 4.7±2.1
uncertainty
(MUIS-A scale) 4
diﬃculty in grasping physical condition  5 0.64 0～20 5.5±3.6
uncertainty regarding the treatment  3 0.67 0～12 4.1±2.8
anxiety about prognosis  3 0.67 0～12 4.8±2.8
diﬃculty in understanding clinical condition  5 0.56 0～20 5.1±2.8
dietary behavior 1
balanced diet eats well, maintains adequate calorie 
intake, uses light seasoning, does not use dressing, 
restricts protein, eats vegetables at every meal
 6 0.78 0～24 17.4±4.6
symptom 1
constipation, fatigue, aches, decreased vision, foot 
pain, edema, decreased concentration, palpitations 
while walking
 8 0.7 0～16 4.3±3.1
social support 3
supportive healthcare staﬀ  4 0.75 0～16 12.3±2.8
lack of support  4 0.73 0～16 1.9±2.5
positive support 10 0.92 0～40 23.0±9.8
knowledge of
nephropathy 1
≪A factor to aggravate nephropathy≫
diabetic control is bad, long medical history of 
diabetes, genetic factor, Hypertension, cigarette, 
therapeutic interruption, lack of dietary energy, 
≪about diabetic nephropathy≫
stage of diabetic nephropathy, remisssion, 
regresion
10 0.74 0～10 5.2±2.3
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Results
　 Background factors. Table 2 shows the 
patients characteristics.  The patients included 57 men 
and 65 women.  The mean age was 60.2±12.5 years,  
and the mean duration of diabetes was 11.7±9.9 
years (1-40 years).  The mean HbA1c was 7.16±1.3ｵ.  
Fifty-two of the subjects (42.6ｵ) were employed.  
Educational background showed that 56 patients 
(45.9ｵ) had attended vocational college or obtained 
higher education.  Regarding family size,  19 patients 
(15.6ｵ) lived alone,  41 (33.6ｵ) lived with 1 person,  
and 62 (50.8ｵ) lived with 3 or more persons.  The 
patients were classiﬁed according to the nephropathy 
stage,  as indicated in the clinical records; 72 (59.0ｵ) 
had normoalbuminuria,  35 (28.7ｵ) had micro-
albuminuria,  8 (6.6ｵ) had macroalbuminuria,  and 7 
(5.7ｵ) had chronic renal failure.  The data regarding 
the participantsʼ (patients) diabetic regimens at the 
time of the survey were obtained from the patientsʼ 
charts.  Twelve patients (9.8ｵ) received dietary treat-
ment; 60 (49.2ｵ) oral medication; 31 (25.4ｵ) insu-
lin treatment; and 19 (15.6ｵ) oral medication and 
insulin treatment.  Seventy-one patients (58.2ｵ) par-
ticipated in hospital educational programs,  37 
(30.3ｵ) had not participated,  and 14 patients 
(11.5ｵ) didnʼt answer the question (see Table 2).
　 Recognition of kidney status of clinical neph-
ropathy. Table 3 indicates how patients under-
stood their clinical stage of nephropathy.  An accurate 
understanding of the patientsʼ disease condition was 
considered to be as follows; patients with normoalbu-
42 Acta Med.  Okayama　Vol.  64,  No.  1Sumiyoshi et al.
Table 2　 Background factors (n＝122)
number of patients (％)
sex male 57 (46.7)
female 65 (53.3)
age mean±S.D. 60.2±12.5 years
schooling history high school or lower education 65 (53.3)
vocational college or higher education 56 (45.9)
missing 1 (0.8)
family size alone 19 (15.6)
two 41 (33.6)
more than three 62 (50.8)
emopoyment status working 52 (42.6)
not working 69 (56.6)
missing 1 (0.8)
duration of diabetes mean±S.D. 11.7±9.9 years
HbA1c mean±S.D. 7.16±1.3％
treatment of regimen diet therapy 12 (9.8)
oral drug therapy 60 (49.2)
insulin therapy 31 (25.4)
oral drug＋insulin therapy 19 (15.6)
attendance at hospital attend 71 (58.2)
education programs not attend 37 (30.3)
unclear 14 (11.5)
complications neuropathy 26 (21.3)
diabetic retinopathy 39 (32.0)
nephropathy 13 (10.7)
clinical stage of nephropathy normoalbuminuria 72 (59.0)
microalbuminuria 35 (28.7)
overt proteinuria 8 (6.6)
chronic renal failure 7 (5.7)
4
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minuria thought that their kidneys were still good;  
patients with microalbuminuria believed that their 
kidneys could be restored; patients with macroalbu-
minuria knew that complications could be avoided;  
patients with chronic renal failure knew that dialysis 
could be avoided.  Sixty-seven (93.0ｵ) of 72 with 
normoalbuminuria,  8 (22.8ｵ) of 35 with microalbu-
minuria,  and 8 (53.3ｵ) of 15 with macroalbuminuria 
and chronic renal failure had a good understanding of 
their clinical stage of nephropathy.  Compared to the 
patients with macroalbuminuria and chronic renal 
failure,  the patients with microalbuminuria believed 
their kidney stage was better than it really was (p＝
0.053).
　 Factors inﬂuencing dietary behavior. We 
found the following common factors inﬂuenced the 
dietary behavior of diabetic and diabetic nephropathy 
patients: 1.  coping with the problem (diabetic 
patients/diabetic nephropathy: β＝0.478,  p＜0.001/
β＝0.342,  p＜0.01),  2.  anxiety about prognosis 
(diabetic patients/diabetic nephropathy: β＝－0.248,  
p＜0.01/β＝－0.344,  p＜0.01); 3.  male (diabetic 
patients/diabetic nephropathy: β＝－0.254,  p＜
0.01/β＝－0.234,  p＜0.05) (R2＝0.395) (Figs.  1 and 
2).  Furthermore,  we found that speciﬁc factors 
aﬀecting the dietary behavior of diabetes nephropathy 
patients were 1.  uncertainty regarding treatment (β
＝0.377,  p＜0.01); 2.  negative coping (β＝－0.354,  
p＜0.01); 3. employment status (β＝0.367,  p＜
0.01),  (R2＝0.632) (Fig.  2).
　 Relationship between background factors and 
the patientʼs coping, uncertainty in illness.
ʻCoping with the problemʼ had a signiﬁcant relation to 
age (r＝0.36,  p＜0.001),  HbA1c (r＝－0.26,  p＜
0.05),  and positive support (r＝0.21,  p＜0.05),  
ʻNegative copingʼ was signiﬁcantly associated with ʻlack 
of supportʼ (r＝0.35,  p＜0.001) and symptom (r＝
0.32,  p＜0.001) (Table 4).
　 ʻUncertainty regarding the treatmentʼ had a signiﬁ-
cant relation to family size (alone 5.5±3.4/two 3.6±
2.6,  p＜0.05),  ʻlack of supportʼ (r＝0.26,  p＜0.01),  
ʻpositive supportʼ (r＝－0.22,  p＜0.05),  and symp-
toms (r＝0.19,  p＜0.05).  ʻAnxiety about prognosisʼ 
had a signiﬁcant relation to attendance at the hospital 
education program (attend 4.3±2.7/nonattendance 
5.8±2.6,  p＜0.01),  clinical stage of nephropathy 
(normoalbuminuria 5.3±2.7/microalbuminuria 3.9±
2.5,  p＜0.05),  awareness of microaluminuria or mac-
roalbuminuria (pointed/not pointed 4.0±2.9/5.2±
2.7,  p＜0.05),  recognition of renal status (normal 5.0
±2.7/abnormal 3.7±3.0,  p＜0.05),  and ʻlack of sup-
portʼ (r＝0.33,  p＜0.001) (Table 4).
Discussion
　 Of the 122 patients included in this study,  50 
(41ｵ) had nephropathy that ranged from microalbu-
minuria to chronic renal failure.  In a previous study 
of 8,817 Japanese patients with diabetes mellitus,  a 
similar proportion (42ｵ) had diabetic nephropathy 
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Table 3　 Recognition of renal status based on of clinical stage
number of patinets (%) n＝122
recognition of renal status
clinical stage of nephropathy
normo
aluminuria
micro
albuminuria
macro
proteinuria &
chronic renal
failure
total
normal 67(93.0%) 25(73.5%) 7(46.7%) 99
return normally  3( 4.2%)  4(11.8%) 1( 6.7%) 8
not become worse by onesʼ eﬀort  1( 1.4%)  4(11.8%) 4(26.6%) 9
not avoid dialysis 0 0 3(20.0%) 3
need dialysis soon  1( 1.4%) 0 0 1
does not understand 0  1( 2.9%) 0 1
total 72(100%) 34(100%)1 did not form 15(100%) 122
 correct recognition
5
Sumiyoshi et al.: Influencing Factors for Dietary Behaviors of Patientswith Diabeti
Produced by The Berkeley Electronic Press, 2010
44 Acta Med.  Okayama　Vol.  64,  No.  1Sumiyoshi et al.
Coping with
the problem 
Anxiety about
prognosis
sex (male)
Dietary
behavior
r2＝0.395
0.478 ＊＊＊－0.248 ＊＊
－
0.2
54
＊＊
Diﬃculty in understanding
clinical condition
0.268＊＊
age
0.251
＊＊
Fig. 1　 Relationship among the patientʼs background factors,  
uncertainty,  coping and dietary behavior patients of diabetes mel-
litus.　n=122.  ＊＊p＜0.01,  ＊＊＊p＜0.001.
Coping with
the problem
Anxiety about
prognosis
sex (male)
Dietary
behavior
r2=0.632
0.342 ＊＊－0.344 ＊＊
－
0.2
34
＊
Uncertainty regarding
the treatment
0.376＊＊
Negative coping
－0.354
＊＊
Employment status
0.36
7＊
＊
Fig. 2　 Relationship among the patientʼs background factors,  
uncertainty,  coping and dietary behavior patients of diabetic neph-
ropathy.　n=50.  ＊p＜0.05,  ＊＊p＜0.01.
Table 4　 The relationship among background factors,  coping scale,  unceratinty scale and dietary behavior
coping scale
coping with the 
problem
expectations
of treatment
negative
coping
positive
attitude
sex (n＝122) male (n＝58) 11.9±4.1 5.9±2.7＊ 2.4±2.7 4.5±2.1
female (n＝64) 11.5±4.4 4.9±2.6 2.7±2.7 4.8±2.2
age (n=122) r＝0.36＊＊＊ r＝0.23＊ r＝－0.02 r＝0.18＊
schooling history (n＝121) high school or lower education (n＝65) 11.5±4.0 5.5±2.7 2.7±2.7 4.9±2.1
vocational college or higher education (n＝56) 11.9±4.5 5.2±2.8 2.5±2.7 4.4±2.1
famiry size (n＝122) alone (n＝19) 11.0±4.4 5.8±2.8 3.8±2.6 4.3±2.6
two (n＝41) 12.4±4.6 5.2±2.8 2.1±2.8 4.8±2.1
more than three (n＝62) 11.4±4.0 5.3±2.6 2.5±2.6 4.7±2.0
employment status (n＝121) working (n＝52) 10.9±4.2 5.2±2.4 2.3±2.3 4.3±2.2
not working (n＝69) 12.2±4.2 5.5±2.9 2.8±2.9 4.9±2.1
duration of diabetes r＝0.17 r＝－0.03 r＝－0.002 r＝－0.006
HbA1c (n=122) r＝－0.26＊ r＝－0.21＊ r＝－0.12 r＝－0.16
treatment of regimen (n=122) diet/oral (n＝72) 11.7±4.3 5.4±2.7 2.3±2.4 4.6±2.1
insulin (n＝50) 11.7±4.2 5.2±2.8 3.0±3.0 4.7±2.2
attendance at hospital education 
programs (n=108)
attend (n＝71) 11.5±4.4 5.1±2.9 2.6±2.7 4.8±2.0
not attend (n＝37) 11.8±4.0 5.7±2.6 2.9±2.9 4.4±2.5
clinical stage of nephropathy 
(n=122)
normoalbumiuria (n＝72) 11.7±4.6 5.2±2.6 2.9±2.9 4.5±2.3
microalbuminuria (n＝35) 11.6±4.0 5.8±2.9 2.3±2.5 4.7±1.7
overt proteinuria/chronic renal failure (n＝15) 11.7±3.4 4.7±2.8 1.7±1.5 5.1±2.4
awareness of microalbuminuria or 
macroalbuminuria (n＝121)
pointed (n＝47) 11.7±4.5 5.3±3.0 2.3±2.8 4.8±2.3
not pointed (n＝74) 11.7±4.1 5.4±2.6 2.7±2.6 4.6±2.0
recgnition of renal status
(n＝120)
normal (n＝99) 11.6±4.3 5.3±2.6 2.7±2.8 4.5±2.1
abnormal (n＝21) 11.7±4.0 5.6±3.2 2.0±1.9 5.2±2.0
social support (n=122) supportive healthcare staﬀ r＝0.12 r＝0.09 r＝0.08 r＝0.22＊
lack of support r＝－0.002 r＝－0.17 r＝0.35＊＊＊ r＝0.05
positive support r＝0.21＊ r＝0.19＊ r＝－0.12 r＝0.22
symptom (n=122) r＝－0.05 r＝－0.30＊＊ r＝0.32＊＊＊ r＝0.01
knowledge of nephropathy (n=122) r＝0.1 r＝0.09 r＝－0.02 r＝0.25＊＊
＊p＜0.05　　＊＊p＜0.01　　＊＊＊p＜0.001
6
Acta Medica Okayama, Vol. 64 [2010], Iss. 1, Art. 6
http://escholarship.lib.okayama-u.ac.jp/amo/vol64/iss1/6
[27].
　 Recognition of kidney status. The patients 
with microalbuminuria thought that the condition of 
their kidneys was better than it really was.  It was 
diﬃcult for the patients to recognize the factors relat-
ing to their renal state or to note and understand its 
relation to albuminuria.  One of the reasons is the lack 
of somatic experiences or symptoms in almost all 
patients with microalbuminuria [28].  Another reason 
is that patients with microalbuminuria did not require 
a strict restriction of dietary protein intake,  and it 
was diﬃcult to understand the seriousness of their 
condition even if the patient received an explanation of 
their kidney status.
　 Coping. Our investigation showed ʻcoping with 
the problemʼ had a positive eﬀect and ʻnegative copingʼ 
had a negative eﬀect on dietary behavior.  Similar to 
previous studies,  our results show that glycemic con-
trol is better for patients who use active rather than 
emotional coping behaviors [29].
　 Uncertainty in illness. ʻUncertainty regarding 
the treatmentʼ had a positive eﬀect and ʻanxiety about 
prognosisʼ had a negative eﬀect on dietary behavior.  
In other words,  when the level of “anxiety about 
prognosis” is high,  patients feel that self-management 
does not lead to better health.  Therefore,  they are 
less likely to attempt dietary behavior.
　 There have been some reports that patients with a 
poor prognosis can maintain hope for improvement 
when there is uncertainty about the therapies for the 
disease[22].  Uncertainty in illness may make the 
patients more adherent to their therapies because they 
have a hope for improvement.  Our results are similar 
to those reported previously.
　 When patients have uncertainty,  they eventually 
associate uncertainty with “risk” or with “opportu-
nity. ” When patients are faced with a risk,  they take 
actions to control negative emotions,  gather informa-
tion,  and exercise caution to alleviate 
uncertainty in illness [24].  Mishel 
insists that even if uncertainty in illness 
leads to an increase in chronic anxiety,  
there can also be positive eﬀects [30].  
Mishel reports that when a person is 
faced with an uncertain situation,  his or 
her coping behaviors become limited,  and 
that the recognition of uncertainly has 
marked eﬀects on human behaviors [31].  
Although excessive amounts of informa-
tion contribute to stress and lead to 
uncertainty in illness,  it is necessary to 
give information at the appropriate times 
to facilitate self-care and to prevent the 
progress of the disease [32,  33].  
Medical staff should assess their 
patientsʼ perceptions of uncertainty in 
illness before they oﬀer knowledge of 
nephropathy to patients.  Interventions 
provided by medical staﬀ are eﬀective in 
helping patients to modify their behav-
ior,  as reported in the Diabetes 
Prevention Program (DPP) research 
program [34].
　 Social support. ʻCoping with the 
problemʼ had a signiﬁcant correlation 
with positive support,  and ʻnegative cop-
ingʼ had a signiﬁcant correlation with lack 
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Table 4　 Continued from opposite page
uncertainty scale
dietary
behavior
diﬃculty in 
grasping 
physical 
condition
unceratinty 
regarding the 
treatment
anxiety about 
prognosis
diﬃculty in 
understanding 
clinical 
condition
5.6±2.8 4.2±2.5 5.1±2.8 5.3±2.6 16.9±4.4　　
5.4±4.3 4.0±3.0 4.6±2.7 4.8±2.9 18.0±4.7　　
r＝－0.08 r＝0.01 r＝－0.01 r＝0.27＊＊ r＝0.22＊　　　
5.9±3.8 4.4±3.0 4.8±2.7 5.1±2.7 17.3±4.9　　
5.1±3.4 3.8±2.5 4.8±2.8 4.8±2.7 17.6±4.2　　
8.4±4.5＊＊ 5.5±3.4＊ 5.5±2.5 4.6±3.3 14.7±6.1＊＊
4.3±3.0　＊ 3.6±2.6 4.1±2.7 5.2±2.6 19.0±4.0　　
5.4±3.3 4.0±2.6 5.1±2.8 5.1±2.7 17.2±4.1　　
5.7±3.5 4.1±2.9 4.8±2.8 4.7±2.8 16.5±4.9＊　
5.3±3.7 4.1±2.7 4.7±2.7 5.2±2.5 18.2±4.3　　
r＝0.14 r＝0.15 r＝0.09 r＝－0.02 r＝－0.04　　
r＝0.17 r＝0.09 r＝0.045 r＝－0.11 r＝－0.19＊　
4.5±3.4＊＊＊ 4.1±2.7 4.6±2.8 5.2±2.8 17.6±4.5　　
7.0±3.4 4.1±2.9 5.1±2.7 4.8±2.7 17.2±4.7　　
5.5±3.6 3.9±2.7 4.3±2.7＊＊ 4.6±2.5 17.8±5.0　　
5.6±4.0 4.6±3.1 5.8±2.6 5.5±2.5 17.8±3.9　　
5.5±3.7 4.2±2.8 5.3±2.7＊ 3.6±2.1 17.4±4.8　　
5.6±3.7 4.1±2.9 3.9±2.5 3.0±2.2 17.5±4.8　　
5.2±3.5 3.7±2.3 4.8±3.1 3.0±2.1 17.5±3.3　　
5.4±4.2 4.1±3.3 4.0±2.9＊ 4.7±2.8 17.5±5.5　　
5.6±3.2 4.1±2.4 5.2±2.7 3.4±2.1 17.4±4.0　　
5.3±3.4 4.1±2.7 5.0±2.7＊ 5.1±2.8 17.2±4.7　　
5.6±4.2 4.0±3.4 3.7±3.0 4.8±2.7 18.7±4.1　　
r＝0.09 r＝－0.09 r＝－0.09 r＝－0.33＊＊ r＝0.05　　　　
r＝0.42＊＊＊ r＝0.26＊＊ r＝0.33＊＊＊ r＝0.07 r＝－0.19　　
r＝－0.2＊ r＝－0.22＊ r＝－0.04 r＝－0.09 r＝0.12　　　　
r＝0.44＊＊＊ r＝0.19＊ r＝0.15 r＝0.04 r＝－0.04　　
r＝－0.06 r＝－0.17 r＝－0.15 r＝－0.12 r＝0.2＊　　　　
＊p＜0.05　　＊＊p＜0.01　　＊＊＊p＜0.001
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of support.  Positive support had a signiﬁcant negative 
correlation with ʻuncertainty regarding the treatment, ʼ 
and lack of support had a signiﬁcant correlation with 
ʻuncertainty regarding the treatmentʼ and ʻanxiety 
about prognosis. ʼ In other words,  social support did 
not have a direct inﬂuence on dietary behavior,  but it 
had an inﬂuence on coping and uncertainty in illness.
　 In a prospective study of type 2 diabetic adults,  it 
was found that a decrease in social support is predic-
tive of a worsening of blood glucose control over time 
[35,  36].  Support from oneʼs spouse has been found 
to be the most important source of support during ill-
ness episodes,  although disruptions in the marital 
relationship often occur when a partner has a chronic 
illness [37].  To maintain appropriate dietary behav-
ior of diabetic patients,  the medical staﬀ must be 
aware of the social supports available to the patient,  
and it is necessary to oﬀer support for family mem-
bers as well.
　 Conclusions. The present ﬁndings indicate 
that information regarding the stage of nephropathy is 
important in getting patients to alter their lifestyle.  
Uncertainty has direct negative and positive eﬀects on 
dietary behaviors; These eﬀects appear to be largely 
dependent on how patients perceive uncertainty.  It is 
particularly important to moderate anxiety for patients 
with diabetic nephropathy.  To improve uncertainty in 
illness,  ʻnegative copingʼ,  and ʻcoping with the prob-
lemʼ,  the medical staﬀ need to be aware of the social 
supports available to the patient,  and it is necessary 
to ensure good communication among healthcare per-
sonnel and positive support for patients and families.
　 Limitations. In order to verify the present 
model and to establish more concrete assistance mea-
sures,  it will be necessary to conduct a prospective 
interventional study.
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